Skip to content

Clinical trials

Terminated Mesothelioma, Malignant trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Mesothelioma, Malignant Status: Terminated Country / region: United States Clear all

32 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20042
20061
20071
20081
20101
20133
20154
20161
20171
20183
20193
20202
20211
20223
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated32

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)6
Verastem, Inc.3
Aduro Biotech, Inc.1
Aminex Therapeutics, Inc.1
Arkadiusz Z. Dudek, MD1
Augusta University1
Burzynski Research Institute1
Columbia University1
Dana-Farber Cancer Institute1
Fred Hutchinson Cancer Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Mesothelioma, Malignant32
Carcinoma, Non-Small-Cell Lung10
Esophageal Neoplasms5
Mesothelioma5
Colorectal Neoplasms4
Melanoma4
Ovarian Neoplasms4
Sarcoma4
Stomach Neoplasms3
Cholangiocarcinoma2

Trials

Showing 1 to 25 of 32. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.